ObjectiveTo study the relative bioavailability and evaluate the bioequivalence of cetirizine hydrochloride chewable tablets in Chinese volunteers.MethodsThe concentrations of cetirizine hydrochloride in plasma following oral administration at a single dose in a randomized crossover study were detected by a HPLCUV method and the pharmacokinetic parameters were calculated by DAS2.0 software for assessing the bioequivalence.ResultsAfter oral administration of 20 mg preparations of the test and reference,respectively,the obtained pharmacokinetic parameters were as follows: AUC0→t were(5.814±1.454) and(5.802±1.028) μg8226;mL-18226;h,respectively;AUC0→∞were(6.358±1.617)and(6.236±1.186) μg8226;mL-18226;h,respectively;Cmax were(0.749±0.149)and(0.716±0.153) μg8226;mL-1,respectively; tmax were(0.819±0.391)and(1.000±0.429) h,respectively;t1/2 were(7.332±0.199)and(7.375±1.420) h,respectively.The relative bioavailability of the test tablet was(99.9±17.5)%.ConclusionThe method established for content detection of cetirizine hydrochloride in plasma is in consistent with the requirements for relative bioavailability study.The test preparations and the reference ones are bioequivalent.